CEMIP has also been implicated in the pathogenesis of multiple sclerosis (MS), a disease characterized by inflammatory demyelination in the CNS, leading to sensory, motor, and cognitive dysfunction (15, 16). This evidence concerns the gene CEMIP and myeloid sarcoma.